The clinical value of Mb and Cys C combined with modified HEART score in emergency chest pain
-
摘要: 目的:探讨肌红蛋白(Mb)、胱抑素C(Cys C)联合改良HEART评分法在鉴别诊断急诊心源性胸痛危险分层的临床价值。方法:选择369例我院接诊的急诊胸痛患者,其中271例为心源性胸痛(心源性胸痛组),98例为非心源性胸痛(非心源性胸痛组)。均进行血清Mb、Cys C检测和改良HEART评分、传统HEART评分评估,分析Mb、Cys C联合改良HEART评分对心源性胸痛鉴别价值。结果:心源性胸痛组血清Mb、Cys C水平、改良HEART评分、传统HEART评分均高于非心源性胸痛组(P<0.05),Logistic回归分析Mb、Cys C、改良HEART评分与心源性胸痛的发生密切相关(P<0.01)。受试者工作特征曲线(ROC)分析结果示Mb、Cys C、改良HEART评分、Mb+Cys C+改良HEART评分鉴别心源性胸痛的曲线下面积(AUC)分别为0.783、0.737、0.872、0.933。结论:联合Mb、Cys C和改良HEART评分可提高对急诊胸痛病因鉴别的准确率,指导急诊胸痛危险分层。Abstract: Objective:To investigate the clinical value of myoglobin(Mb), cystatin C(Cys C) combined with modified HEART score in the differential diagnosis of acute cardiogenic chest pain risk stratification. Method: Three hundred and sixty-nine patients with acute chest pain in our hospital were selected, among which 271 were cardiac chest pain(cardiac chest pain group) and 98 were non-cardiac chest pain(non-cardiac chest pain group). Mb and Cys C tests, improved HEART score and traditional HEART score were performed on all patients, and the value of Mb and Cys C combined improved HEART score in the identification of cardiogenic chest pain was analyzed. Result: The levels of serum Mb, Cys C, modified HEART score and traditional HEART score in the cardiogenic chest pain group were all higher than those in the non-cardiogenic chest pain group(P<0.05). Logistic regression analysis showed that Mb, Cys C and improved HEART score were correlated with the occurrence of cardiogenic chest pain(P<0.01). The Receiver operator characteristics curve(ROC) analysis results showed that the area under the curve(AUC) of Mb, Cys C, modified HEART score and Mb+Cys C+ modified HEART score for the identification of cardiogenic chest pain were 0.783, 0.737, 0.872, 0.933, respectively.Conclusion: The combination of Mb, Cys C and modified HEART score can improve the accuracy of identifying the etiology of chest pain in emergency, and guide the risk stratification of chest pain in emergency.
-
Key words:
- myoglobin /
- cystatin C /
- modified HEART score /
- emergency /
- cardiogenic chest pain
-
-
[1] 顾海峪,何少峰.以急性胸痛为主诉的患者的病因分析[J].实用心脑肺血管病杂志,2014,22(8):125-126,.
[2] Mockel M,Stork T.Acute chest pain[J].Internist(Berl),2017,58(9):900-907.
[3] Aydin S,Ugur K,Aydin S,et al.Biomarkers in acute myocardial infarction:current perspectives[J].Vasc Health Risk Manag,2019,15:1-10.
[4] Larsen TR,Gerke O,Diederichsen ACP,et al.Lack of association between cystatin C and different coronary atherosclerotic manifestations[J].Scand J Clin Lab Invest,2017,77(8):574-581.
[5] Stopyra JP,Harper WS,Higgins TJ,et al.Prehospital Modified HEART Score Predictive of 30-Day Adverse Cardiac Events[J].Prehosp Disaster Med,2018,33(1):58-62.
[6] Ishak M,Ali D,Fokkert MJ,et al.Fast assessment and management of chest pain patients without ST-elevation in the pre-hospital gateway(FamouS Triage):ruling out a myocardial infarction at home with the modified HEART score[J].Eur Heart J Acute Cardiovasc Care,2018,7(2):102-110.
[7] 王繁麟,余娇,王伟,等.改良HEART评分法对急诊胸痛患者分层治疗的指导价值研究[J].现代生物医学进展,2018,18(15):2878-2881,2889.
[8] 席建宏.急性生理与慢性健康评分结合TIMI危险评分对急性冠脉综合征患者预后的预测价值[J].中华现代护理杂志,2015,21(26):3129-3131.
[9] 辛天宇,刘树元,单毅.实验室检查对急性胸痛性质鉴别的意义[J].解放军医药杂志,2016,28(5):87-90.
[10] Goncalves SM,Gomes KB,Carvalho MDG,et al.Effectiveness to identify acute myocardial infarction using the Manchester screening in patients with chest pain at the emergency service[J].J Clin Lab Anal,2018,2:e22439.
[11] Hung CL,Chien DK,Shih SC,et al.The feasibility and diagnostic accuracy by multiple cardiac biomarkers in emergency chest pain patients:a clinical analysis to compare 290 suspected acute coronary syndrome cases stratified by age and gender in Taiwan[J].BMC Cardiovasc Disord,2016,16(1):191.
[12] Pyati AK,Devaranavadagi BB,Sajjannar SL,et al.Heart-Type Fatty Acid-Binding Protein,in Early Detection of Acute Myocardial Infarction:Comparison with CK-MB,Troponin I and Myoglobin[J].Indian J Clin Biochem,2016,31(4):439-445.
[13] 罗显洪,张绪涛,李雪,等.血清胱抑素C水平与冠心病的关系及其对预后的预测价值[J].中西医结合心脑血管病杂志,2016,14(24):2930-2932.
[14] Gevorgyan MM,Voronina NP,Goncharov NV,et al.Cystatin C as a marker of progressing cardiovascular events during coronary heart disease[J].Bull Exp Biol Med,2017,162(4):421-424.
[15] Dandana A,Gammoudi I,Chalghoum A,et al.Clinical utility of serum Cystatin C in predicting coronary artery disease in patients without chronic kidney disease[J].J Clin Lab Analys,2014,28(3):191-197.
[16] Flores-Blanco PJ,López-Cuenca A,Januzzi JL,et al.Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Non-ST-Segment Elevation Acute Coronary Syndrome[J]Clin Cardiol,2016,39(9):507-515.
[17] Reini K,Fredrikson M,Oscarsson A.The prognostic value of the Modified Early Warning Score in critically ill patients:a prospective,observational study[J].Eur J Anaesthesiol,2012,29(3):152-157.
[18] Zhu Y,Wang X,Wang W,et al.Expression and influence of pentraxin-3,HbAlc and ApoA1/ApoB in serum of patients with acute myocardial infarction combined with diabetes mellitus type 2[J].Exp Ther Med,2018,15(5):4395-4399.
[19] 郭进利,窦梦怡,张玉平,等.糖化血红蛋白与2型糖尿病合并急性冠脉综合征患者冠脉病变的关系分析[J].中西医结合心脑血管病杂志,2017,15(2):224-226.
[20] 吕淑杰,翟羽佳.缺血修饰白蛋白在急性心肌梗死早期诊断中的价值分析[J].中国地方病防治杂志,2018,33(2):187-189.
[21] 林松梅,韩贤珍,王宝磊,等.改良HEART评分法指导急诊胸痛患者分层:治疗的应用价值[J].疑难病杂志,2016,15(6):575-578,583.
-
计量
- 文章访问数: 453
- PDF下载数: 387
- 施引文献: 0
下载: